| |
|
|
|
De Rode Hoed, Amsterdam
13 - 16 March 2017
This conference will update you on advances in personalised cancer medicine, focusing on targeted and immunological therapeutic approaches. It will cover the challenges of tumour heterogeneity, drug resistance and the influence of the tumour microenvironment. The conference will bring together basic, translational and clinical scientists, as well as physicians engaged in the challenges of personalised medicine, the development of new therapeutics and clinical implementation.
|
|
|
|
|
|
|
|
Organized by:
|
|
European Association for Cancer Research |
|
|
Invited Speakers:
|
|
Christian Blank (Netherlands), Hans Clevers (Netherlands), Caroline Dive (UK), Jeffrey Engelman (USA), Margaret Frame (UK), Eyal Gottlieb (UK), Meritxell Huch (UK), Roger Lo (USA), Núria Lopez-Bigas (Spain), Richard Marais (UK), Daniel Peeper (Netherlands), Maria Sabilia (Austria), Joan Seoane (Spain), David Solit (USA), Giorgio Stanta (Italy), Matthew Vander Heiden (USA), Emile Voest (Netherlands), Lars Zender (Germany)
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
20 January 2017
|
|
|
|
|
|
|
|
Registration:
|
|
Deadline: 13 February 2017
|
|
|
E-mail:
|
|
kathryn.wass@nottingham.ac.uk
|
|
|
|
|
|
|
|
|